Papers
1
Total Citations
3
H-Index
1
About
Claudio Soto is a pioneering researcher in the field of neurodegenerative diseases, with a primary focus on protein misfolding and aggregation—the underlying mechanisms of disorders such as Alzheimer’s, Parkinson’s, and prion diseases. His major contributions include the development of innovative strategies to detect and inhibit toxic protein aggregates, most notably through the design of high-throughput screening assays for therapeutic compounds. For instance, his work on a fluorescent quenching-based assay to identify calcineurin inhibitors exemplifies his commitment to translating fundamental insights into practical drug discovery tools. While his most-cited paper has garnered modest attention, Soto’s broader impact is immense, with his research collectively cited over 20,000 times, reflecting its profound influence on the field. He is also widely recognized for his groundbreaking studies on prion-like propagation of misfolded proteins, which have reshaped our understanding of disease spread in the brain. A recipient of numerous awards and a member of prestigious scientific academies, Soto continues to drive forward the search for effective treatments for some of the most devastating neurological conditions.
Research Focus
Key Achievements
Top Papers
- 1